Adaptive Cognitive Assessments with Dynamic Difficulty Adjustment to Improve Biomarker Responsiveness in Alzheimer’s Disease

S. Belashew

18th Clinical Trials on Alzheimer's Disease (CTAD) Conference, Biotech Showcase Presentation, 2025, December 2, San Diego, CA, USA

‹ Accurate quantification of steps from multiple smartphone positions

Indivi Secures CHF 15 Million Investment to Accelerate the Discovery of Treatment Response Biomarkers in Neuroscience Drug Development, Targeting Alzheimer’s Disease ›